Quratis Inc. (KOSDAQ: 348080)

Market Cap	38.40B
Revenue	n/a
Net Income	n/a
Shares Out	42.15M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	553,670
Open	898.00
Previous Close	907.00
Day's Range	879.00 - 950.00
52-Week Range	622.00 - 4,030.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Quratis

Quratis Inc. engages in developing vaccines in South Korea. It is involved in developing QTP101, a vaccine for tuberculosis; dendritic cell-based cell therapy for indications, including cancer, autoimmune, and infectious diseases; and peptide nucleic acid-based antimicrobial agents. The company also offers drugs contract development and manufacturing services. Quratis Inc. was founded in 2016 and is based in Seoul, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 348080